Sabrina Pagano

Geneve, GE, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

Environmental pollution, apolipoprotein A-1 autoantibodies and cardiovascular risk: evidence from a geospatial cross-sectional study.

Environmental pollution, apolipoprotein A-1 autoantibodies and cardiovascular risk: evidence from a geospatial cross-sectional study.

Journal: Atherosclerosis plus

Published: March 20, 2026

Interleukin-18 binding protein protects against metabolic steatohepatitis.

Interleukin-18 binding protein protects against metabolic steatohepatitis.

Journal: Hepatology communications

Published: May 12, 2025

Autoimmunity in MASLD: Focus on autoantibodies, anti-apolipoprotein A1 IgG and G protein-coupled receptors.

Autoimmunity in MASLD: Focus on autoantibodies, anti-apolipoprotein A1 IgG and G protein-coupled receptors.

Journal: European journal of clinical investigation

Published: March 11, 2025

Association between SARS-CoV-2 infection and anti-apolipoprotein A-1 antibody in children.

Association between SARS-CoV-2 infection and anti-apolipoprotein A-1 antibody in children.

Journal: Frontiers in immunology

Published: November 01, 2024

Linking Antibodies Against Apolipoprotein A-1 to Metabolic Dysfunction-Associated Steatohepatitis in Mice.

Linking Antibodies Against Apolipoprotein A-1 to Metabolic Dysfunction-Associated Steatohepatitis in Mice.

Journal: International journal of molecular sciences

Published: September 30, 2024

False positive on macrotroponin

False positive on macrotroponin

Journal: Revue medicale suisse

Published: July 18, 2024

Autoantibodies to apolipoprotein A-I in hepatitis C virus infection: a role in disease progression?

Autoantibodies to apolipoprotein A-I in hepatitis C virus infection: a role in disease progression?

Journal: Frontiers in immunology

Published: July 07, 2024

Anti-apolipoprotein A-1 IgG, incident cardiovascular events, and lipid paradox in rheumatoid arthritis.

Anti-apolipoprotein A-1 IgG, incident cardiovascular events, and lipid paradox in rheumatoid arthritis.

Journal: Frontiers in cardiovascular medicine

Published: February 14, 2024

People living with HIV display increased anti-apolipoprotein A1 auto-antibodies, inflammation, and kynurenine metabolites: a case-control study.

People living with HIV display increased anti-apolipoprotein A1 auto-antibodies, inflammation, and kynurenine metabolites: a case-control study.

Journal: Frontiers in cardiovascular medicine

Published: November 23, 2023

Association of Trace Element Levels with Outcomes in Critically Ill COVID-19 Patients.

Association of Trace Element Levels with Outcomes in Critically Ill COVID-19 Patients.

Journal: Nutrients

Published: July 04, 2023

Antibody against apolipoprotein-A1, non-alcoholic fatty liver disease and cardiovascular risk: a translational study.

Antibody against apolipoprotein-A1, non-alcoholic fatty liver disease and cardiovascular risk: a translational study.

Journal: Journal of translational medicine

Published: June 19, 2023

Serum Level of Cytokeratin 18 (M65) as a Prognostic Marker of High Cardiovascular Disease Risk in Individuals with Non-Alcoholic Fatty Liver Disease.

Serum Level of Cytokeratin 18 (M65) as a Prognostic Marker of High Cardiovascular Disease Risk in Individuals with Non-Alcoholic Fatty Liver Disease.

Journal: Biomolecules

Published: June 16, 2023

Showing 1-12 of 66

Last Updated: 09/26/2026